Nirsevimab Library
This is a collection of current resources related to Nirsevimab.
Respiratory Syncytial Virus-An Update for Prenatal and Primary Health Providers
2023
· University of Washington,
· State University of New York - Upstate Medical University,
· Seattle Children's Hospital
This article provides an update on respiratory syncytial virus (RSV) for prenatal and primary health providers. It emphasizes the lack of data on RSV infection …
Ask aRCie
Respiratory Syncytial Virus Infection: Old Challenges and New Approaches
2023
· St. Jude Children's Research Hospital,
· Instituto de Investigación Sanitaria Gregorio Marañón (IISGM),
· Nationwide Children's Hospital
This article discusses respiratory syncytial virus (RSV), a major threat to child health causing acute and long-term morbidity. It explains the structure and function of …
For Indigenous Infants, RSV Prevention is Better Than a Cure
2023
· University of Toronto
This article discusses the importance of preventing respiratory syncytial virus (RSV) in Indigenous infants, particularly focusing on the high rates of RSV-related hospital admissions among …
The Beginning of a New Era in RSV Control
This commentary discusses the historical development and recent advancements in RSV control, focusing on antiviral therapy, passive immunoprophylaxis, and vaccines. It highlights the licensing of …
Implications of Food and Drug Administration Approval of Respiratory Syncytial Virus Prophylactic Medication
This brief article discusses the implications of the FDA approval of nirsevimab, a monoclonal antibody, for preventing respiratory syncytial virus (RSV) lower respiratory tract infections …
Respiratory Syncytial Virus Vaccination Recommendations and Other Updates From ACIP
2023
· University of Michigan
This 2-page practice guideline highlights the impact of respiratory syncytial virus (RSV) infection in the United States, causing severe respiratory illness, especially in infants and …
RSV Prevention - Breakthroughs and Challenges
2023
· Vanderbilt University
This editorial discusses recent advances and ongoing challenges in preventing RSV, a common respiratory virus. The article highlights new methods being developed to protect people, …
Cost-Effectiveness Analysis of Nirsevimab and RSVpreF Vaccine Prevention Strategies for Respiratory Syncytial Virus Disease in Infants: A Canadian Immunisation Research Network (CIRN) Study
2023
· York University,
· Yale University,
· Dalhousie University
This study looks at the cost-effectiveness of two strategies to prevent RSV disease in infants in Canada. It describes using nirsevimab, a long-acting antibody, for …
Monoclonal Antibody for the Prevention of Respiratory Syncytial Virus in Infants and Children: A Systematic Review and Network Meta-analysis
2023
· Lanzhou University
This study reviews monoclonal antibodies (mAbs) for preventing respiratory syncytial virus (RSV) in infants and children. It describes how nirsevimab, motavizumab, and palivizumab reduce RSV-related …
Respiratory Syncytial Virus Prevention: A New Era of Vaccines
2023
· Jiangsu University,
· University of Massachusetts,
· Mayo Clinic,
· Johns Hopkins University,
· Rochester Regional Health,
· Mir Neurology
This editorial discusses new vaccines for preventing respiratory syncytial virus (RSV) infections. RSV affects the lungs and can be serious, especially in young children and …